Cargando…

Dendrimer Prodrugs

The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic pr...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva Santos, Soraya, Igne Ferreira, Elizabeth, Giarolla, Jeanine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274429/
https://www.ncbi.nlm.nih.gov/pubmed/27258239
http://dx.doi.org/10.3390/molecules21060686
_version_ 1783377616221241344
author da Silva Santos, Soraya
Igne Ferreira, Elizabeth
Giarolla, Jeanine
author_facet da Silva Santos, Soraya
Igne Ferreira, Elizabeth
Giarolla, Jeanine
author_sort da Silva Santos, Soraya
collection PubMed
description The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community.
format Online
Article
Text
id pubmed-6274429
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62744292018-12-28 Dendrimer Prodrugs da Silva Santos, Soraya Igne Ferreira, Elizabeth Giarolla, Jeanine Molecules Review The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community. MDPI 2016-05-31 /pmc/articles/PMC6274429/ /pubmed/27258239 http://dx.doi.org/10.3390/molecules21060686 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
da Silva Santos, Soraya
Igne Ferreira, Elizabeth
Giarolla, Jeanine
Dendrimer Prodrugs
title Dendrimer Prodrugs
title_full Dendrimer Prodrugs
title_fullStr Dendrimer Prodrugs
title_full_unstemmed Dendrimer Prodrugs
title_short Dendrimer Prodrugs
title_sort dendrimer prodrugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274429/
https://www.ncbi.nlm.nih.gov/pubmed/27258239
http://dx.doi.org/10.3390/molecules21060686
work_keys_str_mv AT dasilvasantossoraya dendrimerprodrugs
AT igneferreiraelizabeth dendrimerprodrugs
AT giarollajeanine dendrimerprodrugs